Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Evaluation of the EDTA-Modified Carbapenem Inactivation Method (eCIM) for Detecting Metallo-β-lactamase-producing Pseudomonas aeruginosa.

Gill CM, Lasko MJ, Asempa TE, Nicolau DP.

J Clin Microbiol. 2020 Apr 1. pii: JCM.02015-19. doi: 10.1128/JCM.02015-19. [Epub ahead of print]

PMID:
32238433
2.

Metallo-β-lactamase resistance in Enterobacteriaceae is an artefact of currently utilized antimicrobial susceptibility testing methods.

Asempa TE, Abdelraouf K, Nicolau DP.

J Antimicrob Chemother. 2020 Apr 1;75(4):997-1005. doi: 10.1093/jac/dkz532.

PMID:
31930305
3.

Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in a Neutropenic Murine Thigh Infection Model.

Asempa TE, Abdelraouf K, Carabeo T, Schuch R, Nicolau DP.

Antimicrob Agents Chemother. 2020 Feb 21;64(3). pii: e02176-19. doi: 10.1128/AAC.02176-19. Print 2020 Feb 21.

PMID:
31818816
4.

Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model.

Asempa TE, Motos A, Abdelraouf K, Bissantz C, Zampaloni C, Nicolau DP.

Int J Antimicrob Agents. 2020 Feb;55(2):105838. doi: 10.1016/j.ijantimicag.2019.10.019. Epub 2019 Nov 6.

PMID:
31705960
5.

Application of the Hartford Hospital Nomogram for Plazomicin Dosing Interval Selection in Patients with Complicated Urinary Tract Infection.

Asempa TE, Kuti JL, Seroogy JD, Komirenko AS, Nicolau DP.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00148-19. doi: 10.1128/AAC.00148-19. Print 2019 Oct.

6.

In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa.

Asempa TE, Nicolau DP, Kuti JL.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00997-19. doi: 10.1128/AAC.00997-19. Print 2019 Sep.

7.

A Simulated Application of the Hartford Hospital Aminoglycoside Dosing Nomogram for Plazomicin Dosing Interval Selection in Patients With Serious Infections Caused by Carbapenem-Resistant Enterobacterales.

Asempa TE, Kuti JL, Seroogy JD, Komirenko AS, Nicolau DP.

Clin Ther. 2019 Aug;41(8):1453-1462. doi: 10.1016/j.clinthera.2019.04.038. Epub 2019 Jun 24.

PMID:
31248681
8.

Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents.

Asempa TE, Nicolau DP, Kuti JL.

J Clin Microbiol. 2019 Jul 26;57(8). pii: e00535-19. doi: 10.1128/JCM.00535-19. Print 2019 Aug.

9.

Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model.

Asempa TE, Motos A, Abdelraouf K, Bissantz C, Zampaloni C, Nicolau DP.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02382-18. doi: 10.1128/AAC.02382-18. Print 2019 Apr.

10.

Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261-269].

Kidd JM, Avery LM, Asempa TE, Nicolau DP, Kuti JL.

Clin Ther. 2018 Nov;40(11):1956. doi: 10.1016/j.clinthera.2018.09.013. Epub 2018 Oct 16. No abstract available.

PMID:
30336952
11.

Pharmacodynamics of Daptomycin against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.

Kidd JM, Abdelraouf K, Asempa TE, Humphries RM, Nicolau DP.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00506-18. doi: 10.1128/AAC.00506-18. Print 2018 Oct.

12.

Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.

Asempa TE, Avery LM, Kidd JM, Kuti JL, Nicolau DP.

Am J Health Syst Pharm. 2018 Jul 15;75(14):1048-1056. doi: 10.2146/ajhp170839. Epub 2018 Jun 12. Erratum in: Am J Health Syst Pharm. 2018 Dec 1;75(23):1848.

PMID:
29895521
13.

Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.

Kidd JM, Avery LM, Asempa TE, Nicolau DP, Kuti JL.

Clin Ther. 2018 Feb;40(2):261-269. doi: 10.1016/j.clinthera.2017.12.007. Epub 2017 Dec 28. Erratum in: Clin Ther. 2018 Nov;40(11):1956.

PMID:
29290374
14.

Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.

Asempa TE, Rebellato LM, Hudson S, Briley K, Maldonado AQ.

Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13162. Epub 2017 Dec 25.

PMID:
29161757
15.

Clostridium difficile infection in the elderly: an update on management.

Asempa TE, Nicolau DP.

Clin Interv Aging. 2017 Oct 24;12:1799-1809. doi: 10.2147/CIA.S149089. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center